학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 1,020건 | 목록 1~20
Academic Journal
Mallick U; Department of Oncology, Freeman Hospital, Newcastle, UK.; Newbold K; Head, Neck and Thyroid Unit, Royal Marsden NHS Foundation Trust, London, UK.; Beasley M; Bristol Cancer Institute, University Hospitals Bristol and Weston Foundation NHS Trust, Bristol, UK.; Garcez K; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.; Wadsley J; Department of Oncology, Weston Park Cancer Centre, Sheffield, UK.; Johnson SJ; Department of Cellular Pathology, Royal Victoria Infirmary, Newcastle upon Tyne, UK.; Stephenson T; Laboratory Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; Gaze M; Department of Oncology, University College London Hospitals NHS Foundation Trust, London, UK.; Goodman A; Department of Oncology, Royal Devon and Exeter Hospital, Devon, UK.; Jefferies S; Department of Oncology, Addenbrooke's Hospital, Cambridge, UK.; Sivabalasingham S; Department of Oncology, University College London Hospitals NHS Foundation Trust, London, UK.; Slevin N; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.; Wilkinson DP; Department of Radiotherapy and Oncology, James Cook University Hospital, Middlesbrough, UK.; Macias-Fernandez E; Department of Nuclear Medicine, Kent and Canterbury Hospital, Canterbury, UK.; Power D; Department of Oncology, Imperial College Healthcare NHS Trust, London, UK.; Roques T; Department of Clinical Oncology, Norfolk and Norwich University Hospital Trust, Norwich, UK.; Speed L; Department of Oncology, University Hospitals of Leicester NHS Trust, Leicester, UK.; Nutting C; Head, Neck and Thyroid Unit, Royal Marsden NHS Foundation Trust, London, UK.; Mochloulis G; Department of Ear, Nose and Throat and Head and Neck Surgery, East and North Herts NHS Trust, Stevenage, UK.; Gerrard G; Department of Oncology, St James's University Hospital, Leeds, UK.; Candish C; Department of Oncology, Cheltenham General Hospital, Cheltenham, UK.; Morgan S; Department of Oncology, Nottingham University Hospitals NHS Trust, Nottingham, UK.; Tripathi D; Department of Oncology, New Cross Hospital, Wolverhampton, UK.; Truran P; Department of Surgery, Royal Victoria Infirmary, Newcastle upon Tyne, UK.; Arthur C; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.; Wieczorek A; Queens Centre for Oncology, Castle Hill Hospital, Cottingham, UK.; Madhavan K; Department of Oncology, Southend University Hospital, Southend, UK.; Maclean J; Department of Oncology, Velindre Hospital, Cardiff, UK.; Boote D; Portsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth, UK.; Kim D; St George's University Hospital, London, UK.; Pascoe A; Department of Oncology, Nottingham University Hospitals NHS Trust, Nottingham, UK.; Pitiyage G; Department of Cellular Pathology, St George's University Hospital, London, UK.; Forsyth S; Cancer Research UK & UCL Cancer Trials Centre, UCL Cancer Institute, London, UK.; Ambrose E; Cancer Research UK & UCL Cancer Trials Centre, UCL Cancer Institute, London, UK.; Chang E; Cancer Research UK & UCL Cancer Trials Centre, UCL Cancer Institute, London, UK.; Farnell K; Butterfly Thyroid Cancer Trust, Newcastle, UK.; Hackshaw A; Cancer Research UK & UCL Cancer Trials Centre, UCL Cancer Institute, London, UK. Electronic address: a.hackshaw@ucl.ac.uk.
Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE
Academic Journal
Oguejiofor, K K, Hall, J S, Mani, N, Douglas, C, Slevin, N J, Homer, J, Hall, G & West, C M L 2013, 'The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.', Clinical Oncology, vol. 25, no. 11, pp. 630-638. https://doi.org/10.1016/j.clon.2013.07.003, https://doi.org/doi:10.1016/j.clon.2013.07.003
Academic Journal
Webster, G J, Kilgallon, J E, Ho, K F, Rowbottom, C G, Slevin, N J & Mackay, R I 2009, 'A novel imaging technique for fusion of high-quality immobilised MR images of the head and neck with CT scans for radiotherapy target delineation', British Journal of Radiology, vol. 82, no. 978, pp. 497-503. https://doi.org/10.1259/bjr/50709041
Academic Journal
Bernstein, J, Douglas, C M, Bernstein, J M, Ormston, V E, Hall, R C, Merve, A, Swindell, R, Valentine, H R, Slevin, N J, West, C M L & Homer, J J 2013, 'Lack of Prognostic Effect of Carbonic Anhydrase-9, Hypoxia Inducible Factor-1α and Bcl-2 in 286 Patients with Early Squamous Cell Carcinoma of the Glottic Larynx Treated with Radiotherapy', Clinical Oncology, vol. 25, no. 1, pp. 59-65. https://doi.org/10.1016/j.clon.2012.07.004
Douglas, CM, Bernstein, JM, Ormston, VE, Hall, RC, Merve, A, Swindell, R, Valentine, HR, Slevin, NJ, West, CM & Homer, JJ 2012, 'Lack of Prognostic Effect of Carbonic Anhydrase-9, Hypoxia Inducible Factor-1α and Bcl-2 in 286 Patients with Early Squamous Cell Carcinoma of the Glottic Larynx Treated with Radiotherapy', Clin Oncol, vol. 24, no. Epub.
Academic Journal
Ghosal, N, Mais, K, Shenjere, P, Julyan, P, Hastings, D, Ward, T, Ryder, W D, Bruce, I, Homer, J & Slevin, N J 2011, 'Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinoma', British Journal of Oral and Maxillofacial Surgery, vol. 49, no. 7, pp. 510-515. https://doi.org/10.1016/j.bjoms.2010.09.013
Academic Journal
Silva, P, Slevin, N J, Sloan, P, Valentine, H, Ryder, D, Price, P, West, C M L & Homer, J J 2010, 'Use of multiple biological markers in radiotherapy-treated head and neck cancer.', The Journal of laryngology and otology, vol. 124, no. 6. https://doi.org/10.1017/S0022215110000228
Academic Journal
Ho, K F, Farnell, D J J, Routledge, J A, Burns, M P, Sykes, A J, Slevin, N J & Davidson, S E 2009, ' Developing a CTCAEs patient questionnaire for late toxicity after head and neck radiotherapy ', European Journal of Cancer, vol. 45, no. 11, pp. 1992-1998 . https://doi.org/10.1016/j.ejca.2009.04.010
Academic Journal
Isa, A Y, Ward, T H, West, C M L, Slevin, N J & Homer, J J 2006, 'Hypoxia in head and neck cancer', British Journal of Radiology, vol. 79, no. 946, pp. 791-798. https://doi.org/10.1259/bjr/17904358
Academic Journal
Lawrance, J A L, Mais, K L & Slevin, N J 2003, 'Radiologically inserted gastrostomies: Their use in patients with cancer of the upper aerodigestive tract', Clinical Oncology, vol. 15, no. 3, pp. 87-91.
Academic Journal
Br J Cancer
Renehan, A G, Gleave, E N, Slevin, N J & McGurk, M 1999, 'Clinico-pathological and treatment-related factors influencing survival in parotid cancer', British Journal of Cancer, vol. 80, no. 8, pp. 1296-1300. https://doi.org/10.1038/sj.bjc.6990501
검색 결과 제한하기
제한된 항목
[검색어] SLEVIN, N. J.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어